Calcium antagonists and chronic cardiac failure.
作者信息
Kendall M J, Horton R C, Smith S R
出版信息
Postgrad Med J. 1986 Aug;62(730):713-7. doi: 10.1136/pgmj.62.730.713.
Abstract
摘要
相似文献
1
Calcium antagonists and chronic cardiac failure.钙拮抗剂与慢性心力衰竭
Postgrad Med J. 1986 Aug;62(730):713-7. doi: 10.1136/pgmj.62.730.713.
2
[Use of calcium antagonists in the treatment of cardiac insufficiency].[钙拮抗剂在治疗心脏功能不全中的应用]
Ther Umsch. 1984 Feb;41(2):125-30.
3
[Calcium antagonists in congestive heart failure].[充血性心力衰竭中的钙拮抗剂]
G Ital Cardiol. 1988 Nov;18(11):989-96.
4
Calcium channel blockers in left ventricular dysfunction or congestive heart failure.左心室功能不全或充血性心力衰竭中的钙通道阻滞剂
Conn Med. 1997 Oct;61(10):659-61.
5
Calcium antagonists in heart failure.心力衰竭中的钙拮抗剂
Herz. 1983 Apr;8(2):88-92.
6
Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
Compr Ther. 1981 Oct;7(10):25-33.
7
[Calcium antagonists in the treatment of arterial hypertension].[钙拮抗剂在动脉高血压治疗中的应用]
Pol Tyg Lek. 1982 Nov 15;37(44):1327-9.
8
Calcium antagonists in secondary prevention after myocardial infarction.心肌梗死后二级预防中的钙拮抗剂
Drugs. 1991;42 Suppl 2:54-60. doi: 10.2165/00003495-199100422-00009.
9
[Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].钙拮抗剂在心力衰竭药物治疗中的作用
Rev Port Cardiol. 1989 Jul-Aug;8(7-8):547-52.
10
Calcium channel blockers in heart failure.心力衰竭中的钙通道阻滞剂
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):139A-144A. doi: 10.1016/0735-1097(93)90478-j.
引用本文的文献
1
Calcium antagonists in patients with heart failure. A review.心力衰竭患者中的钙拮抗剂。综述。
Drugs. 1991 Sep;42(3):343-64. doi: 10.2165/00003495-199142030-00002.
本文引用的文献
1
Unpredictable response to nifedipine in severe cardiac failure.重度心力衰竭患者对硝苯地平反应不可预测。
Br Med J. 1980 Nov 15;281(6251):1324. doi: 10.1136/bmj.281.6251.1324.
2
Hemodynamic effects of nifedipine in congestive heart failure.硝苯地平在充血性心力衰竭中的血流动力学效应。
Am J Cardiol. 1980 Sep;46(3):476-80. doi: 10.1016/0002-9149(80)90018-1.
3
Calcium antagonists prevent early post-infarction ventricular fibrillation.钙拮抗剂可预防心肌梗死后早期心室颤动。
Eur J Pharmacol. 1981 Nov 5;75(4):179-85. doi: 10.1016/0014-2999(81)90543-4.
4
Verapamil disposition kinetics in chronic atrial fibrillation.维拉帕米在慢性心房颤动中的处置动力学
Clin Pharmacol Ther. 1981 Jul;30(1):44-51. doi: 10.1038/clpt.1981.125.
5
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease.心室功能障碍严重程度对缺血性心脏病患者静脉注射维拉帕米后血流动力学反应的影响。
Am J Cardiol. 1981 Apr;47(4):917-22. doi: 10.1016/0002-9149(81)90194-6.
6
Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function.舌下含服硝苯地平的急性血流动力学反应：取决于左心室功能。
Circulation. 1982 Mar;65(3):489-98. doi: 10.1161/01.cir.65.3.489.
7
The 24-hour ambulatory blood pressure profile with verapamil.使用维拉帕米的24小时动态血压监测情况
Circulation. 1982 Jan;65(1):22-7. doi: 10.1161/01.cir.65.1.22.
8
Clinical manifestations and pathophysiology of myocardial ischemia with special reference to coronary artery spasm and the role of slow channel calcium blockers.心肌缺血的临床表现及病理生理学，特别涉及冠状动脉痉挛和慢通道钙阻滞剂的作用。
Prog Cardiovasc Dis. 1982 Sep-Oct;25(2):157-68. doi: 10.1016/0033-0620(82)90026-3.
9
Nifedipine in unstable angina: a double-blind, randomized trial.硝苯地平治疗不稳定型心绞痛：一项双盲随机试验
N Engl J Med. 1982 Apr 15;306(15):885-9. doi: 10.1056/NEJM198204153061501.
10
The clinical use of intravenous verapamil.静脉注射维拉帕米的临床应用。
Am Heart J. 1980 Dec;100(6 Pt 2):1070-5. doi: 10.1016/0002-8703(80)90215-x.
Zotero 插件